drug
EFINACONAZOLE
Marketedupdated 3mo agoby Ortho Dermatologics Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 1all catalysts(1)
Trials studying EFINACONAZOLE
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 3, 2028
~1.4 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (18)
- Apr 25, 2035formulationUS 10478601
- Oct 2, 2034formulationUS 10342875
- Oct 2, 2034method-of-use (U-2720)US 10828293
- Oct 2, 2034method-of-use (U-2720)US 10864274
- Oct 2, 2034method-of-use (U-1969)US 11654139
- Oct 2, 2034formulationUS 9662394
- Oct 24, 2030formulationUS 84869784.2y
- Oct 24, 2030formulationUS 93020094.2y
- Jul 8, 2030formulationUS 101054443.9y
- Jul 8, 2030method-of-use (U-281)US 80394943.9y
- Jul 8, 2030formulationUS 98616983.9y
- Jan 3, 2028method-of-use (U-1969)US 105126401.4y
- Jan 3, 2028formulationUS 108283691.4y
- Jan 3, 2028method-of-use (U-2720)US 112135191.4y
- Jan 3, 2028method-of-use (U-1969)US 118722181.4y
- Jan 3, 2028method-of-use (U-1969)US 95662721.4y
- Jan 3, 2028method-of-use (U-1969)US 98779551.4y
- Feb 22, 2026method-of-use (U-281)US 7214506
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that